Physician profile
John M Ramirez
NPI 1922155100
$1,120.05
in general payments reported to CMS, 2019-2025
11 companies · $48.99 in 2025
The $48.99 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $699 · 2020: $148 · 2021: $92.67 · 2023: $102 · 2024: $29.59 · 2025: $48.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $181.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $533.87 | 2019-2021 | |
| Organogenesis INC. | $175.41 | 2019 | |
| Ethicon US, LLC | $104.17 | 2019 | |
| Cardiva Medical, INC. | $62.88 | 2024-2025 | Savvywire, Optowire |
| Hydrofera LLC | $51.93 | 2023 | Hydrofera Blue, Cutimed Sorbact |
| Integra Lifesciences Corporation | $50.95 | 2019 | |
| Boston Scientific Corporation | $50.53 | 2023 | Watchman Access System |
| Smith+Nephew, INC. | $49.56 | 2019-2020 | |
| Abiomed | $15.70 | 2024 | Impella |
| Amniox Medical, INC. | $14.04 | 2019 | |
| Olympus America INC. | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.